Cargando…

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice

BACKGROUND: The pathology of Alzheimer's disease (AD) is comprised of extracellular amyloid plaques, intracellular tau tangles, dystrophic neurites and neurodegeneration. The mechanisms by which these various pathological features arise are under intense investigation. Here, expanding upon pilo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dickey, Chad A, Gordon, Marcia N, Wilcock, Donna M, Herber, Donna L, Freeman, Melissa J, Morgan, Dave
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549198/ https://www.ncbi.nlm.nih.gov/pubmed/15689237 http://dx.doi.org/10.1186/1471-2202-6-7

Ejemplares similares

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
por: Wilcock, Donna M, et al.
Publicado: (2004)

Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice
por: Carty, Nikisha, et al.
Publicado: (2013)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
por: Weekman, Erica M, et al.
Publicado: (2014)

Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
por: Carty, Niki C, et al.
Publicado: (2006)

Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
por: Latta, Clare H, et al.
Publicado: (2015)

Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses
por: Wilcock, Donna M, et al.
Publicado: (2011)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
por: Geng, Pengcheng, et al.
Publicado: (2018)

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice
por: Li, Bin, et al.
Publicado: (2011)

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Iván, et al.
Publicado: (2013)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
por: Carrera, Ivan, et al.
Publicado: (2014)

Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease
por: Arora, Tushar, et al.
Publicado: (2023)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019)

Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β-amyloid production and tau hyperphosphorylation
por: Zhong, Lili, et al.
Publicado: (2018)

EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways
por: Tsay, Huey-Jen, et al.
Publicado: (2021)

Direct interaction of beta-amyloid with Na,K-ATPase as a putative regulator of the enzyme function
por: Petrushanko, Irina Yu., et al.
Publicado: (2016)

Na,K-ATPase Acts as a Beta-Amyloid Receptor Triggering Src Kinase Activation
por: Petrushanko, Irina Yu., et al.
Publicado: (2022)

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence
por: Wilcock, Donna M, et al.
Publicado: (2011)

Tanshinone IIA Alleviates the AD Phenotypes in APP and PS1 Transgenic Mice
por: Li, Fengling, et al.
Publicado: (2016)

The effects of treadmill exercise on autophagy in hippocampus of APP/PS1 transgenic mice
por: Zhao, Na, et al.
Publicado: (2018)

Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice
por: Li, Qingyou, et al.
Publicado: (2004)

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)

Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice
por: Li, Xuying, et al.
Publicado: (2014)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
por: Luo, Gang, et al.
Publicado: (2016)

Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction
por: Yang, Cuicui, et al.
Publicado: (2020)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022)

NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice
por: Tan, Yan, et al.
Publicado: (2022)

Treadmill exercise promotes E3 ubiquitin ligase to remove amyloid β and P-tau and improve cognitive ability in APP/PS1 transgenic mice
por: Xu, Longfei, et al.
Publicado: (2022)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice
por: Rijal Upadhaya, Ajeet, et al.
Publicado: (2013)

Alzheimer’s Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station
por: DiChiara, Thomas, et al.
Publicado: (2017)

Na(+)/Ca(2+) exchange and Na(+)/K(+)-ATPase in the heart
por: Shattock, Michael J, et al.
Publicado: (2015)

VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice
por: Song, Min, et al.
Publicado: (2012)

Treadmill Exercise Ameliorates Adult Hippocampal Neurogenesis Possibly by Adjusting the APP Proteolytic Pathway in APP/PS1 Transgenic Mice
por: Yu, Haizhen, et al.
Publicado: (2021)

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
por: Hiltunen, Mikko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8bpe9b316ne8dmnl6hu9nueurd